No Conflicts or Debarment Sample Clauses

No Conflicts or Debarment. Institution will use reasonable efforts to ensure that neither Investigator nor any personnel participating in the Study (a) are under any contractual or other obligations or restrictions which are inconsistent with Institution’s and Investigator’s obligations under this Agreement, (b) have a financial or other interest in Sponsor or the outcome of the Study which might interfere with their independent judgment, or (c) have been debarred, or are under consideration to be debarred, by the United States Food and Drug Administration (the “FDA”) from nemocnice Plzeň, Neurochirurgická klinika, alej Svobody 80, 304 60 Plzeň Zdravotnické zařízení a zkoušející budou provádět studii kompetentním způsobem, v souladu s vysokými vědeckými a profesionálními normami, budou se striktně řídit protokolem, touto smlouvou a pokyny zadavatele a xxx pověřených osob, přičemž zdravotnické zařízení ani zkoušející nebudou používat hodnocené zařízení k žádným jiným účelům. Zdravotnické zařízení a zkoušející budou dodržovat veškeré příslušné zákony, směrnice a doporučení v místě, kde se studie provádí, což zahrnuje mimo jiné směrnice Mezinárodní rady pro harmonizaci technických požadavků týkajících se humánních léčivých přípravků, správnou klinickou praxi (tzv. „ICH/GCP“) a veškeré další platné zákony a směrnice týkající se ochrany osobních údajů. Zdravotnické zařízení a zkoušející uplatnili a uzavřeli se zaměstnanci a/nebo vybranými poskytovateli služeb z řad třetích stran náležité smlouvy týkající se použití, zpracování a předávání osobních údajů v souladu s nařízením Evropské unie o ochraně fyzických osob v souvislosti se zpracováním osobních údajů a o volném pohybu těchto údajů (tzv. GDPR). 2.2
Sample 1
AutoNDA by SimpleDocs
No Conflicts or Debarment. MSK will ensure that MSK, the Investigator-Sponsor, and other Study personnel, to the best of MSK’s knowledge: (a) are under no contractual obligation that would knowingly breach this Agreement; (b) do not have any undisclosed financial or other interest in Company or the outcome of the Study that would knowingly interfere with their independent judgment; (c) have not been, and are not under consideration to be (i) debarred from providing services pursuant to Section 306 of the United States Federal Food, Drug and Cosmetic Act 21 U.S.C. §335a; (ii) excluded, debarred or suspended from, or otherwise ineligible to participate in any federal or state health care programs or federal procurement or non-procurement programs (as that term is defined in 42 U.S.C. §1320a-7b(f)); (iii) disqualified by any government or regulatory agencies from performing specific services, and are not subject to a pending disqualification proceeding; or (iv) convicted of a criminal offense related to the provision of health care items or services. During each Study, to the extent permitted by law, MSK will notify Company immediately if MSK, the Investigator-Sponsor, and any other Study personnel are subject to the foregoing.
Sample 1Sample 2

Related to No Conflicts or Debarment

  • No Conflicts, etc The execution, delivery, and performance by the Company of the Transaction Documents, the consummation by the Company of the transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time or both: (i) result in a breach or violation of, or conflict with any of the terms and provisions of, or constitute a default under, or result in the creation, modification, termination or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any agreement, obligation, condition, covenant or instrument to which the Company is a party or bound or to which its property is subject except pursuant to the Trust Agreement; (ii) result in any violation of the provisions of the Amended and Restated Certificate of Incorporation and Bylaws of the Company, each as may be amended (collectively, the “Charter Documents”); or (iii) violate any existing applicable statute, law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its properties, assets or business constituted as of the date hereof.

  • No Conflicts and No Violation The completion of the transactions contemplated by this Agreement and the performance of the Asset Representations Reviewer’s obligations under this Agreement will not (i) conflict with, or be a breach or default under, any indenture, loan agreement, guarantee or similar document under which the Asset Representations Reviewer is a debtor or guarantor, (ii) result in the creation or imposition of a Lien on the properties or assets of the Asset Representations Reviewer under the terms of any indenture, loan agreement, guarantee or similar document, (iii) violate the organizational documents of the Asset Representations Reviewer or (iv) violate a law or, to the Asset Representations Reviewer’s knowledge, an order, rule or regulation of a federal or State court, regulatory body, administrative agency or other governmental instrumentality having jurisdiction over the Asset Representations Reviewer or its property that applies to the Asset Representations Reviewer, which, in each case, would reasonably be expected to have a material adverse effect on the Asset Representations Reviewer’s ability to perform its obligations under this Agreement.

  • No Conflicts with Sanctions Laws Neither the Company nor any of its subsidiaries, directors, officers, or employees, nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently the subject or the target of any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”) or the U.S. Department of State and including, without limitation, the designation as a “specially designated national” or “blocked person”), the United Nations Security Council (“UNSC”), the European Union, Her Majesty’s Treasury (“HMT”) or other relevant sanctions authority (collectively, “Sanctions”), nor is the Company or any of its subsidiaries located, organized or resident in a country or territory that is the subject or target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea and Syria (each, a “Sanctioned Country”); and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.

Time is Money Join Law Insider Premium to draft better contracts faster.